NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the ...
Stakeholders from different industries convened to discuss the roadmap ahead to become the next innovation powerhouse at ...
Purple Biotech (PPBT) is advancing into a Phase 2 study with NT219 in patients with recurrent/metastatic squamous cell carcinoma of the head ...
Signs an Amended & Restated License Agreement for Multiple Technologies for Gene Therapy for Type 1 and Type 2 Diabetes Forms a Wholl ...
KL Deemed to be University is happy to announce that Lakshmi Soumya Emani, a Ph.D. scholar in Biotechnology, has earned the ...
The Modesto Bee on MSN4d
From fashion to finance, Modesto high schools offer over a dozen career and technical pathsAll high schools, including Elliot Alternative, offer the design, visual and media arts pathway. Davis, Downey, Gregori and ...
The Joint Department of Biomedical Engineering, a collaboration between NC State and UNC-CH, received a $20 million ...
The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the standard-of-care head and neck cancer drugs pembrolizumab (Keytruda) or cetuximab ...
“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback